IPXL Impax Laboratories Inc.

-0.80  -3%
Previous Close 23.80
Open 23.70
Price To book 3.25
Market Cap 1709188627
Shares 74,312,549
Volume 1,568,711
Short Ratio 4.03
Av. Daily Volume 1,768,268

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL January 21 2013. Approved Jan 8 2015

Latest News

  1. Could this East Bay generic drug maker have the urge to merge?
  2. [$$] Impax Laboratories in Talks to Merge With Amneal Pharmaceuticals
  3. Should You Buy Impax Laboratories Inc (IPXL) Now?
  4. Why Calgon Carbon, Kindred Healthcare, and Impax Laboratories Jumped Today
  5. Impax Shares Jump on Merger Buzz
  6. Generic drugmaker Impax Labs in talks to merge with Amneal - WSJ
  7. Impax to Present at the Cantor Fitzgerald Global Healthcare Conference
  8. U.K. Firm Impax to Buy Pax World Management
  9. ETFs with exposure to Impax Laboratories, Inc. : September 13, 2017
  10. Impax Laboratories, Inc. :IPXL-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
  11. FDA's Letter To Pfizer Won't Hurt EpiPen Market
  12. Corporate News Blog - Merck to Acquire German immuno-oncology Company Rigontec
  13. Impax to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
  14. Impax Laboratories, Inc. (IPXL) in Focus: Stock Moves 20.6% Higher
  15. Impax Shares Jump After Chinese Firm Reveals 5% Stake
  16. Stocks With Rising Relative Price Strength: Impax Laboratories
  17. Impax Laboratories, Inc. – Value Analysis (NASDAQ:IPXL) : August 19, 2017
  18. Edited Transcript of IPXL earnings conference call or presentation 9-Aug-17 12:30pm GMT
  19. Impax Laboratories (IPXL) Q2 Earnings Beat, Revenues Up Y/Y
  20. Why Impax Laboratories Inc Is Up for a Second Straight Day